AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01642914 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linaclotide 290 micrograms
Description: oral capsule, taken once daily each morning at least 30 minutes before breakfast
Study NCT01642914 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linaclotide 145 micrograms
Description: oral capsule, taken once daily each morning at least 30 minutes before breakfast
Study NCT01642914 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Matching placebo
Description: oral capsule, taken once daily each morning at least 30 minutes before breakfast
Study NCT04317183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chamomile topical oral gel
Description: Chemical constituents of chamomile, such as bisabolol, chamazulene, and the flavonoids apigenin and luteolin, possess anti-inflammatory properties.
Study NCT04317183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Miconazole Topical Gel
Description: topical anti fungal agent
Study NCT04317183 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Miconazole Topical Gel
Description: topical anti fungal agent
Study NCT04317183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BBC oral spray
Description: Topical anesthetics and anti-inflammatory agent
Study NCT04317183 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BBC oral spray
Description: Topical anesthetics and anti-inflammatory agent
Study NCT05141734 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: The relationship between the vestibulo-ocular reflex (VOR) gains and the slow phase velocity (SPV)
Description: The vestibulo-ocular reflex (VOR) gains were measured by video Head Impulse Test (vHIT) in both the study group and the control group. The slow phase velocity (SPV) values of the nystagmus observed during the Dix-Hallpike maneuver in the study group were recorded by Videonystagmography (VNG) and compared with the VOR gains.
Study NCT04317183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oracure gel
Description: Topical analgesic gel
Study NCT04317183 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oracure gel
Description: Topical analgesic gel
Study NCT00671138 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Necator americanus
Description: 10 necator americanus larvae will be inoculated at week 0 with a further 5 larvae inoculated at week 12
Study NCT00671138 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sham inoculation
Description: A diluted amount of McIlhenny \& Co Tabasco Pepper Sauce will be applied via a gauze dressing at weeks 0 and 12.
Study NCT03516396 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Training Plus
Description: Training plus enhanced community development activities
Study NCT03516396 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Training Only
Description: Training Only (livestock management and child nutrition) for 24 months then add community development inputs
Study NCT03516396 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: No Inputs then Community development and training
Description: No inputs for 24 months then add community development and training
Study NCT02289235 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ginger
Description: Ginger powder capsule 1000 mg twice daily for 3 months
Study NCT02289235 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo powder 2 capsules twice daily for 3 months
Study NCT01604590 — intervention group
Intervention type: RADIATION
Intervention: Magnetic Resonance Imaging (MRI)
Description: Magnetic Resonance Imaging (MRI) will be used to compare bevacizumab to the images of vessel and tumor structure.
Study NCT03694366 — intervention group
Intervention type: OTHER
Intervention: ICBHSS model
Description: Bundle of evidence-based interventions that include the following 5 components:~1. Community engagement meetings and feedback;~2. Elimination of public sector facility user fees for children under five and pregnant women;~3. Pro-active community based IMCI using trained, equipped, supervised, and salaried Community Health Workers (CHWs) with additional services including linkage to family planning and counseling, HIV testing \& referrals;~4. Clinical mentoring and enhanced supervision by a trained peer coach at public sector facilities;~5. Basic infrastructure improvements and supply chain management training of pharmacy managers
Study NCT00317252 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Hold ACEI or ARB
Description: Angiotensin converting enzyme inhibitor or angiotensin receptor blocker held at least 24 hours pre-cardiac catheterization and restarted 48-96 hours post-catheterization (after creatinine measurement)
Study NCT00317252 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hold ACEI or ARB
Description: Angiotensin converting enzyme inhibitor or angiotensin receptor blocker held at least 24 hours pre-cardiac catheterization and restarted 48-96 hours post-catheterization (after creatinine measurement)
Study NCT02511899 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Mango fruit powder
Description: Dietary supplement; Mango fruit powder
Study NCT01754116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1265744 30 mg oral
Description: GSK1265744B 30 mg Tablet taken orally, once a day in the morning with or without a meal
Study NCT01754116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam 3 mg oral + GSK1265744 30mg oral
Description: Midazolam Syrup 3mg each mL Oral/single dose administer by oral syringe on Day -29 and Day -14
Study NCT01754116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1265744 400 mg (200 nm)
Description: A single dose of GSK1265744 400 mg Intra Muscular (IM) injection (Nanomilled 200 nm)
Study NCT01754116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1265744 400 mg (1 micro m)
Description: A single dose of GSK1265744 400 mg IM injection (Nanomilled 1 micrometer)
Study NCT01754116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1265744 400 mg (5 micro m)
Description: A single dose of GSK1265744 400 mg IM injection (Dry milling and homogenization 5 micrometer)
Study NCT01466452 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aspirin
Description: single-dose aspirin in 100 mg 1 tablet every 24 hours
Study NCT01466452 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aspirin
Description: single-dose aspirin 200 mg 1 tablet every 24 hours
Study NCT01466452 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aspirin
Description: double-dose aspirin 100 mg 1 tablet every 12 hours
Study NCT04890951 — intervention group
Intervention type: PROCEDURE
Intervention: Hysteropexy
Description: Uterine preservation through suspension
Study NCT04890951 — intervention group
Intervention type: PROCEDURE
Intervention: Hysterectomy and vaginal vault suspension
Description: Uterine removal and sewing the vagina upwards
Study NCT01874795 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TENS
Description: Adhesive electrodes (MultiStick®, USA) were placed on each side, about 3 cm to the right and left of midline vertebral process, at C7 (Channel 1) and T4 (Channel 2).
Study NCT01874795 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Placebo
Description: The frequency of stimulation was 80 Hz and the pulse duration was 150 μs, equipment did not provide stimulation current.
Study NCT03241381 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: vitamin D serum assay study and control groups
Description: Serum- vitamin D assay
Study NCT03241381 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Photometry
Description: Serum- Hemoglobin assay
Study NCT03241381 — intervention group
Intervention type: OTHER
Intervention: Russels periodontal index
Description: Clinical examination for periodontitis
Study NCT00393029 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fludarabine phosphate
Description: 25 mg/m2/day intravenously piggyback (IVPB) daily over 30 minutes for 5 days.
Study NCT02227472 — intervention group
Intervention type: OTHER
Intervention: Evaluation of cognitive and pre-academic skills
Description: Participants will complete testing to evaluate fluid reasoning, knowledge, quantitative reasoning, visual-spatial processing, verbal and non-verbal working memory, and knowledge of pre-academic skills (such as colors, letters, numbers, counting, sizes, comparisons, and shapes).
Study NCT02227472 — intervention group
Intervention type: OTHER
Intervention: Parent questionnaires
Description: Parents will complete questionnaires to assess behavioral manifestation of executive functions, functional independence and adaptive functioning, child and parent characteristics, situational/demographic life stress, demographics, education level, and household income.
Study NCT02992704 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peginterferon Alfa-2A
Description: peginterferon alpha 2a 180mcg weekly for either 24 or 48 weeks
Study NCT03242304 — intervention group
Intervention type: OTHER
Intervention: Behavioral tests
Description: We observed relationship between plasma levels of cortisol and neurological, cognitive, functional and emotional outcomes in patients with acute ischemic stroke.
Study NCT02819349 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Texting for Relapse Prevention (T4RP)
Description: T4RP is a relapse prevention mHealth program text messaging to people who have schizophrenia/SAD. Content is guided by components of the Assertive Community Treatment (ACT) and focuses on facilitating improved patient-provider communication, promoting medication adherence, helping people self-monitor their early warning signs, and promoting self-management of symptoms.
Study NCT02494219 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Rapid Immunochromatographic streptococcal test
Description: Throat swab obtained for rapid strep test in addition to throat culture,in order to check the accuracy of Rapid Immunochromatographic streptococcal test in detection of streptococcal pharyngitis
Study NCT04137497 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: The Coma Recovery Scale-Revised and the Nociception Coma Scale-Revised (NCS-R)
Description: All enrolled DOC patients were evaluated at least five times over one week by two trained professionals using the Chinese version of the CRS-R. During the evaluation of the patient's consciousness level, the NCS-R was used to evaluate the pain response of all patients in random order at least once, and the best behavioral response (i.e., the highest score) of each subscale was recorded during resting, noxious, and physiotherapy conditions, respectively, according to the NCS-R guidelines.
Study NCT01471756 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Standard of Care Procedure as described in ARM
Description: Standard of Care Procedure as described in ARM
Study NCT01629316 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text reminders, counseling, and link coordination
Description: This is an intervention with text reminders, counseling that involves motivational interviewing, and link coordination
Study NCT01629316 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care - control arm
Description: The control arm is standard of care for each subject.
Study NCT02267824 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Extraoral OrthoPulse® PBM
Description: Patients carry out daily extraoral OrthoPulse® PBM treatments at home.
Study NCT02267824 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fixed Orthodontic Appliance Treatment
Description: Patients are treated for full mouth fixed orthodontic appliance treatment by the qualified Principal Investigator (PI). Orthodontic treatment procedures carried out per the traditional practices of the PI and dental office.
Study NCT02885649 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enzalutamide
Description: Given PO
Study NCT02885649 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT02885649 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Nephrectomy
Description: Undergo partial or radical nephrectomy
Study NCT04761874 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telestroke
Description: In the telestroke cohort, acute ischemic stroke patients at a single comprehensive stroke center received their stroke care and management exclusively via telestroke.
Study NCT01599130 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Entecavir
Description: entecavir 0.5mg per day
Study NCT01599130 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peginterferon alfa-2a
Description: Peginterferon alfa-2a 180ug per week
Study NCT02512536 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botulinum Toxin Type A
Description: Ultrasound scan guided injection into supraspinatus muscle belly with Botulinum Toxin Type A
Study NCT00439101 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo (lemon-lime suspension) taken orally for 90 days.
Study NCT02642536 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: MH MOVE
Description: provides the standard MOVE! weight management program plus a workbook containing education for management of depression, anxiety and PTSD symptoms to be used during 10 phone based clinician led CBT sessions
Study NCT02642536 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care
Description: provides the standard MOVE! weight management program plus a workbook containing education for management of depression, anxiety and PTSD symptoms but not phone calls are provided.
Study NCT01246622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cytarabine
Description: Given IV
Study NCT01246622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lenalidomide
Description: Given PO
Study NCT00755859 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: steroids plus azathioprine
Description: methylprednisolone 1 g i.v. for three consecutive days at the beginning of months 1, 3 and 5, followed by oral prednisone 0.5 mg/kg every other day plus azathioprine 1.5 mg/kg/day for six months
Study NCT00755859 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: steroids
Description: methylprednisolone 1 g i.v. for three consecutive days at the beginning of months 1, 3 and 5, followed by oral prednisone 0.5 mg/kg every other day for six months
Study NCT02836626 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: deep fascial mobilization
Description: Pelvic and abdominal myofascial release techniques as described by Barnes will be performed to facilitate independent mobility between tissue layers as needed following the direction of palpated fascial tension. Following this, direct scar mobilization techniques as described by Manheim will be done, applying a stretch in the direction of palpated restriction . This involves applying deep pressure whose force and direction is dictated by the tightness the therapist palpates and the subject reports. These are each held until a release is felt (defined as a sudden relaxation of tissue tension), usually 60-120 seconds. Total treatment time will last 25 minutes. Treatments will include all the above techniques but the therapist will tailor each treatment to address palpated restrictions. Subjects will be instructed to carry on their normal routines between sessions and will not be given any home interventions. Treatment sessions will total four to occur within a three week time period.
Study NCT02836626 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: superficial fascial mobilization
Description: This group will undergo four 25-minute sessions of gentle superficial effleurage to the abdomen and posterior trunk followed by superficial skin rolling to the scar. Each treatment session will be terminated a) after 25 minutes or 2) when the patient asks to stop due to discomfort. Reasons for termination will be documented. Subjects will be instructed to carry on their normal routines between sessions and will not be given any home interventions. Treatment sessions will total four to occur within a three week time period.
Study NCT01172483 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: general practice in primary care and education
Description: education of chronic disorders in PC
Study NCT01172483 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multimodal community program
Description: The intervention was an 8-week programme of MMPP combined with DWR, delivered by physiotherapists in groups of 8 to 10 participants. One-hour sessions were conducted 3 times per week, consisting of DWR and an individualised MMPP of therapeutic exercises combined with education based on cognitive-behavioural principles. Each session was comprised of 30 minutes of land-based exercise followed by 20 minutes of DWR, with an additional 10 minutes of warm-up and cool-down time. Deep water running stimulates running using a flotation device in water levels over head height. During the first two weeks of the intervention, participants undertook a low-intensity adaptation interval to learn proper exercise technique. For the remaining six weeks, participants were instructed to maintain a constant speed to achieve the prescribed HRAT. If experiencing pain while exercising, participants were asked to temporarily reduce intensity and return to target HR as capable.
Study NCT01109563 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Marijuana Check-Ins
Description: The MCI, an MET intervention, will include the provision of personalized feedback with a motivational interviewing style. The focus of these sessions will be individualized to participants based on recent marijuana use and related experiences. Feedback given to participants during the MCI session will review progress toward goals as self-reported in percent days abstinent, normative data regarding marijuana use, review of reported consequences of marijuana use, review of abuse and dependence criteria reported, comparison of consequences and abuse and dependence symptoms reported over time, review of the positive outcomes from reductions in use, and review of immediate and long-term life goals and how their marijuana goal will affect these. HEs will offer particular encouragement to take advantage of CBT sessions to participants who feel they currently need treatment.
Study NCT01109563 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Marijuana Check-Ins
Description: The MCI, an MET intervention, will include the provision of personalized feedback with a motivational interviewing style. The focus of these sessions will be individualized to participants based on recent marijuana use and related experiences. Feedback given to participants during the MCI session will review progress toward goals as self-reported in percent days abstinent, normative data regarding marijuana use, review of reported consequences of marijuana use, review of abuse and dependence criteria reported, comparison of consequences and abuse and dependence symptoms reported over time, review of the positive outcomes from reductions in use, and review of immediate and long-term life goals and how their marijuana goal will affect these. HEs will offer particular encouragement to take advantage of CBT sessions to participants who feel they currently need treatment.
Study NCT05600504 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: no intervention
Study NCT02239341 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Intervention
Description: Music will be about 120 beats per minute and the participants will listen to the music while wearing head-phones in bed.
Study NCT02239341 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Music Intervention
Description: Music will be about 120 beats per minute and the participants will listen to the music while wearing head-phones in bed.
Study NCT02239341 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle Conditioning Intervention
Description: Music will be about 120 beats per minute and the participants will listen to the music while wearing head-phones and also participate in the muscle conditioning program while in bed.
Study NCT01182558 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Hypothenar muscle activation--maximum, voluntary, isometric
Description: Each subject will perform maximum, voluntary, isometric muscle activation (of the target muscle) for each of various durations (single brief muscle twitch, 2 seconds, 5 seconds, 10 seconds, and 20 seconds \[two epochs of 10 seconds of muscle activation with 1-2 seconds of rest between the two epochs\]).
Study NCT01182558 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Thenar muscle activation--maximum, voluntary, isometric
Description: Each subject will perform maximum, voluntary, isometric muscle activation (of the target muscle) for each of various durations (single brief muscle twitch, 2 seconds, 5 seconds, 10 seconds, and 20 seconds \[two epochs of 10 seconds of muscle activation with 1-2 seconds of rest between the two epochs\]).
Study NCT01182558 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: EDB muscle activation--maximum, voluntary, isometric
Description: Each subject will perform maximum, voluntary, isometric muscle activation (of the target muscle) for each of various durations (single brief muscle twitch, 2 seconds, 5 seconds, 10 seconds, and 20 seconds \[two epochs of 10 seconds of muscle activation with 1-2 seconds of rest between the two epochs\]).
Study NCT01182558 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Relaxation of muscle
Description: The muscle on the opposite side will be maintained at rest.
Study NCT00712205 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: once daily 1mcg Placebo for 28days followed by crossover treatment